A U.S. Centers for Medicare & Medicaid Services 18-month ​trial program will offer for the first time Novo Nordisk’s Wegovy ...

Sources confirm to STAT that Marburg cases have been detected in western Uganda, adding another viral hemorrhagic fever ...

Dozens of congressional lawmakers are urging the Trump administration to force Eli Lilly to reinstate mandated price breaks ...

Reducing Medicare payments for 340B drugs is the latest proposal focused on the hotly debated drug discount program.

Elevance Health has sued the U.S. government, alleging that federal efforts to recalculate its Medicare Advantage quality ...

A federal judge blocked a Colorado state panel from placing a cap on the price of Enbrel, a blockbuster drug sold by Amgen ...

What is urgently needed is a shift from pathogen-specific diagnostics toward pathogen-agnostic diagnostic systems,” write ...

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to ...

Vijay Kumar, acting director of the office that reviews cell and gene therapies at the Food and Drug Administration, is ...

CDC leadership continues to try manufacture a scientific debate on vaccines where none exists, writes Ben Lopman.

Biotech's bull market, Vertex's gene therapy expansion, and more news from The Readout ...

The presidential fitness test is back, surprising new data on the health risks of obesity, and more Morning Rounds news ...